{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:43:05Z","timestamp":1774316585386,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00417-016-3281-6","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T03:05:22Z","timestamp":1455073522000},"page":"999-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease"],"prefix":"10.1007","volume":"254","author":[{"given":"David B.","family":"Granet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nickisa","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle J.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don O.","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kinori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"3281_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/bjo.2010.188326","volume":"95","author":"DB Granet","year":"2011","unstructured":"Granet DB (2011) Strabismus: aligning the doctor\u2019s vision with the patient\u2019s need. Br J Ophthalmol 95:443\u2013444. doi: 10.1136\/bjo.2010.188326","journal-title":"Br J Ophthalmol"},{"key":"3281_CR2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11940-009-0054-0","volume":"12","author":"ME Phillips","year":"2010","unstructured":"Phillips ME, Marzban MM, Kathuria SS (2010) Treatment of thyroid eye disease. Curr Treat Options Neurol 12:64\u201369. doi: 10.1007\/s11940-009-0054-0","journal-title":"Curr Treat Options Neurol"},{"key":"3281_CR3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/eye.2012.284","volume":"27","author":"DH Verity","year":"2013","unstructured":"Verity DH, Rose GE (2013) Acute thyroid eye disease (TED): principles of medical and surgical management. Eye (Lond) 27:308\u2013319. doi: 10.1038\/eye.2012.284","journal-title":"Eye (Lond)"},{"key":"3281_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.beem.2011.11.005","volume":"26","author":"C Marcocci","year":"2012","unstructured":"Marcocci C, Marino M (2012) Treatment of mild, moderate-to-severe and very severe Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26:325\u2013337. doi: 10.1016\/j.beem.2011.11.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3281_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11940-014-0303-8","volume":"16","author":"AJ Pillar","year":"2014","unstructured":"Pillar AJ, Richa DC (2014) Treatment options for thyroid eye disease. Curr Treat Options Neurol 16:303. doi: 10.1007\/s11940-014-0303-8","journal-title":"Curr Treat Options Neurol"},{"key":"3281_CR6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.eye.6701768","volume":"19","author":"D Paridaens","year":"2005","unstructured":"Paridaens D, van den Bosch WA, van der Loos TL, Krenning EP, van Hagen PM (2005) The effect of etanercept on Graves\u2019 ophthalmopathy: a pilot study. Eye (Lond) 19:1286\u20131289. doi: 10.1038\/sj.eye.6701768","journal-title":"Eye (Lond)"},{"key":"3281_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","volume":"156","author":"M Salvi","year":"2007","unstructured":"Salvi M, Vannucchi G, Campi I, Curro N, Dazzi D, Simonetta S, Bonara P, Rossi S, Sina C, Guastella C, Ratiglia R, Beck-Peccoz P (2007) Treatment of Graves\u2019 disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol 156:33\u201340. doi: 10.1530\/eje.1.02325","journal-title":"Eur J Endocrinol"},{"key":"3281_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","volume":"87","author":"AB Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044\u20131049","journal-title":"Ophthalmology"},{"key":"3281_CR9","first-page":"734","volume":"79","author":"AB Scott","year":"1981","unstructured":"Scott AB (1981) Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 79:734\u2013770","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3281_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00140912","volume":"58","author":"AB Scott","year":"1984","unstructured":"Scott AB (1984) Injection treatment of endocrine orbital myopathy. Doc Ophthalmol 58:141\u2013145","journal-title":"Doc Ophthalmol"},{"key":"3281_CR11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0161-6420(86)33713-8","volume":"93","author":"WJ Dunn","year":"1986","unstructured":"Dunn WJ, Arnold AC, O\u2019Connor PS (1986) Botulinum toxin for the treatment of dysthyroid ocular myopathy. Ophthalmology 93:470\u2013475","journal-title":"Ophthalmology"},{"key":"3281_CR12","first-page":"1063","volume":"42","author":"X Wu","year":"2006","unstructured":"Wu X, Lin N, Ai LK, Wang JH, Yan LJ (2006) The application of botulinum toxin A in the treatment of restrictive strabismus in thyroid associated ophthalmopathy]. [Zhonghua yan ke za zhi] Chin J Pphthalmol 42:1063\u20131067","journal-title":"[Zhonghua yan ke za zhi] Chin J Pphthalmol"},{"key":"3281_CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1080\/09638280701568189","volume":"29","author":"L Kowal","year":"2007","unstructured":"Kowal L, Wong E, Yahalom C (2007) Botulinum toxin in the treatment of strabismus. A review of its use and effects. Disabil Rehabil 29:1823\u20131831. doi: 10.1080\/09638280701568189","journal-title":"Disabil Rehabil"},{"key":"3281_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1091-8531(99)70022-4","volume":"3","author":"EJ Gair","year":"1999","unstructured":"Gair EJ, Lee JP, Khoo BK, Maurino V (1999) What is the role of botulinum toxin in the treatment of dysthyroid strabismus? J AAPOS 3:272\u2013274","journal-title":"J AAPOS"},{"key":"3281_CR15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (1996) Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284\u2013290","journal-title":"Am J Ophthalmol"},{"key":"3281_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1010020621687","volume":"1","author":"AE Heufelder","year":"2000","unstructured":"Heufelder AE (2000) Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 1:87\u201395","journal-title":"Rev Endocr Metab Disord"},{"key":"3281_CR17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738. doi: 10.1056\/NEJMra0905750","journal-title":"N Engl J Med"},{"key":"3281_CR18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/edrv-10-3-366","volume":"10","author":"TJ Smith","year":"1989","unstructured":"Smith TJ, Bahn RS, Gorman CA (1989) Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 10:366\u2013391. doi: 10.1210\/edrv-10-3-366","journal-title":"Endocr Rev"},{"key":"3281_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaapos.2010.07.005","volume":"14","author":"LR Dagi","year":"2010","unstructured":"Dagi LR, Elliott AT, Roper-Hall G, Cruz OA (2010) Thyroid eye disease: honing your skills to improve outcomes. J AAPOS 14:425\u2013431. doi: 10.1016\/j.jaapos.2010.07.005","journal-title":"J AAPOS"},{"key":"3281_CR20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol 73:639\u2013644","journal-title":"Br J Ophthalmol"},{"issue":"Pt 4","key":"3281_CR21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/eye.1990.74","volume":"4","author":"CJ Lyons","year":"1990","unstructured":"Lyons CJ, Vickers SF, Lee JP (1990) Botulinum toxin therapy in dysthyroid strabismus. Eye (Lond) 4(Pt 4):538\u2013542. doi: 10.1038\/eye.1990.74","journal-title":"Eye (Lond)"},{"key":"3281_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/09273970590935048","volume":"13","author":"EL Dawson","year":"2005","unstructured":"Dawson EL, Sainani A, Lee JP (2005) Does botulinum toxin have a role in the treatment of secondary strabismus?*. Strabismus 13:71\u201373. doi: 10.1080\/09273970590935048","journal-title":"Strabismus"},{"key":"3281_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/0191-3913-19890701-04","volume":"26","author":"KW McNeer","year":"1989","unstructured":"McNeer KW (1989) Botulinum toxin injection into the superior rectus muscle of the non-dominant eye for dissociated vertical deviation. J Pediatr Ophthalmol Strabismus 26:162\u2013164","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"3281_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2012.0119","volume":"29","author":"MK Bittencourt","year":"2013","unstructured":"Bittencourt MK, de Vasconcellos JP, Bittencourt MD, Malago R, Bacellar M (2013) Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs. J Ocul Pharmacol Ther 29:431\u2013436. doi: 10.1089\/jop.2012.0119","journal-title":"J Ocul Pharmacol Ther"},{"key":"3281_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00347-004-1091-4","volume":"102","author":"T Dintelmann","year":"2005","unstructured":"Dintelmann T, Sold J, Grehn F (2005) Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease. Ophthalmologe 102:247\u2013250. doi: 10.1007\/s00347-004-1091-4","journal-title":"Ophthalmologe"},{"key":"3281_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/IOP.0b013e318032eb12","volume":"23","author":"BS Korn","year":"2007","unstructured":"Korn BS, Seo SW, Levi L, Granet DB, Kikkawa DO (2007) Optic neuropathy associated with botulinum A toxin in thyroid-related orbitopathy. Ophthal Plast Reconstr Surg 23:109\u2013114. doi: 10.1097\/IOP.0b013e318032eb12","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"3281_CR27","doi-asserted-by":"crossref","unstructured":"Taylan Sekeroglu H, Kocabeyoglu S, Mocan MC, Muz E, Karakaya J, Irkec M, Sanac AS (2014) Ocular surface changes following botulinum toxin injection for strabismus. Cutan Ocul Toxicol 1\u20134 Doi: 10.3109\/15569527.2014.941996","DOI":"10.3109\/15569527.2014.941996"},{"key":"3281_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9394(02)02092-5","volume":"135","author":"DO Kikkawa","year":"2003","unstructured":"Kikkawa DO, Cruz RC Jr, Christian WK, Rikkers S, Weinreb RN, Levi L, Granet DB (2003) Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure. Am J Ophthalmol 135:427\u2013431","journal-title":"Am J Ophthalmol"},{"key":"3281_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9394(99)00473-0","volume":"129","author":"K Ohtsuka","year":"2000","unstructured":"Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129:613\u2013617","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3281-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3281-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3281-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T20:29:42Z","timestamp":1654288182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3281-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3281"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3281-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}